Study Finds Women Endure 30% More Pain Than Men Worldwide
A new analysis published in Nature Medicine on Tuesday shows women across the globe report about 30 percent more pain than men. The study examined self‑reported pain from over six million participants in 118 nations between 1990 and 2025. Researchers say the finding challenges long‑standing assumptions about gender‑neutral pain thresholds.
Data were drawn from national health surveys, hospital records and longitudinal cohort studies, all harmonised by the Global Pain Consortium. The consortium, led by Dr. Maya Patel of Cambridge, applied uniform pain scales to ensure comparability. Officials said the sheer breadth of the dataset makes the gender gap statistically robust.
Women reported higher scores at each of the eleven anatomical sites examined – head, face, neck or shoulder, foot or ankle, hand or wrist, elbow, chest, back, stomach or abdomen, hip and knee. The average pain intensity difference ranged from 0.4 points on a 10‑point scale for the elbow to 1.2 points for headaches. Experts noted that even modest score increases can translate into significant functional impairment.
With chronic pain already the leading cause of disability worldwide, a gender disparity means millions of women may be under‑treated or misdiagnosed. Health insurers in the United States and public hospitals in India are already reviewing pain‑management protocols in light of the report. The study arrives as the World Health Organization prepares new guidelines on gender‑sensitive care.
The authors call for immediate integration of sex‑specific metrics into clinical trials and routine practice. Next, we explore which pain types show the widest gaps and what biology might be driving them. Failure to act could widen the existing burden on women's quality of life.
Headache, Facial and Abdominal Pain Show Largest Gender Gaps
Among the eleven sites, three stood out with the widest gender gaps: headache, facial pain and abdominal discomfort. Women's average headache score was 6.3 on a ten‑point scale, compared with 5.1 for men, marking a 22 percent higher prevalence. Facial pain averaged 5.8 for women versus 4.6 for men, while abdominal pain recorded 5.5 against 4.2 in male respondents.
- Headache: women's average score 6.3 vs men's 5.1, a 22 % higher prevalence.
- Facial pain: women 5.8 vs men 4.6, a 26 % gap.
- Abdominal pain: women 5.5 vs men 4.2, a 31 % difference.
The researchers say these gaps persisted after adjusting for age, socioeconomic status and comorbidities, suggesting a biological component beyond reporting bias. In South Asia, the abdominal pain gap was especially pronounced, with women in India scoring 1.4 points higher than their male counterparts. In contrast, the gender difference for elbow pain was minimal, indicating that not all body sites follow the same pattern. Dr. Patel explained, "Hormonal cycles amplify nociceptive signalling in the head and gut, which likely drives the stark disparities we see in headache and abdominal pain."
Experts said the findings compel clinicians to ask gender‑focused questions during assessments, rather than assuming a one‑size‑fits‑all approach.
Researchers Cite Hormonal and Neurobiological Factors
The study's authors propose several mechanisms that could explain why women consistently report higher pain levels. Fluctuations in estrogen and progesterone during the menstrual cycle are known to sensitize nerve pathways, especially those serving the head and abdomen. In addition, women tend to have a higher density of certain pain‑receptive receptors, such as TRPV1, which amplify thermal and chemical pain signals.
Long‑term exposure to these hormonal swings may remodel brain circuits involved in pain modulation, making women more vulnerable to chronic pain conditions. Functional MRI scans from a subset of the cohort showed heightened activity in the anterior cingulate cortex of female participants when exposed to standardized pressure stimuli.
"Our neuroimaging data suggest that the female brain processes pain cues more intensely," said Dr. Maya Patel, epidemiologist and lead author. "This does not mean women are weaker; it reflects a distinct physiological response that medicine must respect."
Experts also highlighted social and cultural factors that can influence pain reporting, such as gender norms around expressing discomfort. Nevertheless, the biological signals observed in the study remain robust after controlling for these variables. The authors call for more interdisciplinary research that bridges endocrinology, neuroscience and sociology to fully map the gender pain landscape.
Clinical Practice Lagging Behind Gender Pain Evidence
Despite the mounting evidence, many clinicians continue to treat pain without accounting for gender differences, leading to under‑prescription of analgesics for women. A 2024 audit of prescription data from 45 hospitals in the United Kingdom revealed that women received opioid doses 15 percent lower than men for comparable pain scores. In India, a survey of 12,000 outpatient visits found that women were 22 percent less likely to be offered a referral to a pain specialist.
"We see a systemic bias where women's pain is dismissed as 'just stress' or 'hormonal'," said Prof. Anil Kumar, pain specialist at All India Institute of Medical Sciences. "This translates into fewer prescriptions, longer wait times and poorer outcomes for female patients."
The gap is not limited to pharmaceuticals; women are also less likely to receive advanced interventions such as nerve blocks or spinal cord stimulation. In a private clinic in Mumbai, Dr. Priya Mehta reported that only 8 percent of her female chronic‑pain patients qualified for such procedures, versus 18 percent of men.
Training programs for physicians are beginning to incorporate gender‑sensitive modules, but experts say the rollout is uneven. The authors of the Nature Medicine paper urge medical schools to embed sex‑specific pain assessment into curricula, arguing that early education can shift entrenched prescribing habits.
Policy Makers Urged to Close Gender Pain Gap
Governments worldwide are taking note of the study, with several health ministries announcing task forces to review pain‑management policies. In Delhi, the Ministry of Health and Family Welfare convened a panel chaired by Dr. Renu Sharma, who said, "Our duty is to ensure that every citizen receives equitable care, and that includes recognizing gender‑based differences in pain perception." The panel will draft guidelines that require clinicians to record sex‑disaggregated pain scores in electronic health records.
The European Union's Health Directorate released a statement that the findings will inform its upcoming Horizon Europe funding call on gender‑responsive health research. Experts said the funding could accelerate trials that test sex‑specific dosing of analgesics, a currently under‑explored area.
In the United States, the National Institutes of Health announced a $45 million grant program aimed at developing biomarkers that predict pain trajectories in women. Officials said the initiative hopes to reduce the average time to effective treatment from 18 months to under six months for female patients.
The authors warn that without coordinated policy action, the gender pain gap could widen as populations age and chronic‑pain prevalence rises globally.
What Patients Can Do Now to Advocate for Better Relief
Women experiencing persistent pain can take several steps to ensure their concerns are heard and addressed. First, keep a detailed pain diary that records intensity, location, triggers and menstrual cycle phase; this objective data can strengthen discussions with doctors. Second, ask providers directly about sex‑specific treatment options, such as low‑dose hormonal therapy for menstrual‑related migraines. Third, seek second opinions from pain specialists who are familiar with gender‑sensitive approaches.
Digital health platforms now offer validated pain‑assessment tools that generate printable reports for clinic visits. Organizations like the Women's Health Alliance provide webinars on navigating prescription policies and negotiating insurance coverage.
"Patients are the most powerful allies in closing the gender pain gap," said Maya Desai, patient‑advocate and founder of PainEqual. "When women come prepared with data, clinicians are forced to move beyond assumptions and prescribe appropriately."
Looking ahead, the research team plans a follow‑up trial that will test whether personalized, hormone‑timed analgesic regimens reduce pain scores by at least 20 percent in women with chronic migraine. If successful, the study could reshape prescribing standards worldwide. The momentum generated by the current findings suggests that the next decade may finally see pain care that truly reflects the lived experience of women.